Vincent P. Laudone, MD
Urologic Surgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Robotic Surgery for Genitourinary Cancers
Video DetailsAbout Me
- Chief of Surgery, Josie Robertson Surgery Center
I am a board-certified urologic surgeon who specializes in robotic surgery for people with cancers of the genitourinary system, especially prostate cancer.
I am also Chief of Surgery at MSK’s new Josie Robertson Surgery Center, a pioneering outpatient and short-stay cancer surgery facility located on York Avenue in Manhattan.
Read more
In my personal practice, I see approximately 350 to 400 new prostate cancer patients each year and operate on approximately 250 men annually. I’m in my 28th year of doing cancer surgery exclusively and have more than 12 years of experience with robot-assisted surgery.
Throughout these years, my focus has been to optimize the use of this technology and to ensure that we achieve the very best results for each and every patient. In the case of prostate cancer, this means treating the cancer in the most effective way possible while preserving urinary and sexual function to the maximum extent possible.
We’ve entered the age of what I like to call “technologically enhanced surgery.” The major advance of the past decade has been the introduction of the surgical robot. Going forward, my focus is to further develop technology that will enhance what we see — and therefore what we’re able to do — during surgery.
For example, I’m working with my colleagues on a method to take a three-dimensional rendering of a patient’s prostate MRI and bring it into the surgeon’s visual field as he or she operates. This means that surgeons will have right in front of them a real-time view of the surgical anatomy as well as a detailed MRI as a guide.
Another example of my work involves research to develop an agent that can be given to patients prior to surgery that uses laser light to enhance visualization of nerves to avoid nerve injury during surgery.
No single treatment strategy is right for every man. A treatment decision needs to be based on the extent of the disease and the aggressiveness of the cancer, as well as the age, overall health, and quality of life considerations of the patient and his partner. Some men do very well with what we call active surveillance (sometimes called watchful waiting), meaning that no treatment is needed immediately and we carefully monitor the cancer for any indication that it’s growing or becoming more aggressive. Other men require treatment.
But no patient should ever feel rushed or pressured into making a hasty decision. It’s vital to get information and expert opinions. I also believe it’s important to involve your family — especially your partner, if you have one — in the process so that they too can help gather information, evaluate your options, and support your decision before, during, and after treatment.
Finally, my greatest satisfaction comes in getting to know my patients and their families — learning about what’s important to them and assisting them in making the best possible decisions regarding their cancer care. I want to make certain that whatever decision they arrive at, it will serve them well in the immediate term and for the rest of their lives.
A urologic surgeon is a doctor with special training in surgery on the genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) (GU) system. This includes the bladder, kidney, penis, prostate, and testicles.
My Specialties
- Robotic Surgery
- Prostate Cancer
- Bladder Cancer
Education
- MD, Georgetown University School of Medicine
Residencies
- University of Virginia Medical Center
Awards and Honors
- Castle Connolly: America’s Top Doctor (2024)
- Top Doctors New York Metro Area, Castle Connolly (2023)
- Castle Connolly: America's Top Doctors (2023)
- Member, Alpha Omega Alpha Medical Society
- American Cancer Society Clinical Fellow
- Best Doctors in America (2001 – 2011)
- Top Doctors in Connecticut (2005 – 2011)
Fellowships
- Memorial Sloan Kettering Cancer Center
Board Certifications
- Urology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Laudone sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Laudone
- A Phase 1 Study of Fluorescent Imaging of Nerves with Illuminare-1 during Prostate Cancer Surgery
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Laudone’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Vincent P. Laudone discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].